Advances in Pharmacoepidemiology and Drug Safety

Sasabe H, Shimokawa Y, Shibata M, Hashizume K, Hamasako Y, et al. (2016) Antitubercular agent delamanid and metabolites as substrates and inhibitors of ABC and solute carrier transporters. Antimicrobial agents and chemotherapy 60: 3497-3508.

Stine JG and Lewis JH (2016) Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert review of gastroenterology & hepatology 10: 517-536.

Lewis JH (2015) The art and science of diagnosing and managing drug-induced liver injury in 2015 and beyond. Clinical Gastroenterology and Hepatology 13: 2173-2189.

Amarendra KE (2015) Overview of Pharmacovigilance.

Kumar A, & Khan H (2015) Signal Detection and their Assessment in Pharmacovigilance. Open Pharmaceutical Sciences Journal 2: 1.

Sharma NK & Ahirwar D (2013) Journal Of Harmonized Research (JOHR). Journal Of Harmonized Research in Pharmacy 2: 01-33.

Sri Chandini K (2016) Review on Rosuvastatin.

Roughead EE (2015) Multidrug interactions: the current clinical and pharmacovigilance challenge. Journal of Pharmacy Practice and Research 45: 138-139.

Superiore di Sanità, R. (2015). POLITERAPIE NEI DIABETICI ANZIANI: RISULTATI DI UNO STUDIO CONDOTTO NELLA ASL ROMA D. Appropriatezza prescrittiva, sicurezza e buon uso dei farmaci I RISULTATI DEI PROGETTI DI FARMACOVIGILANZA DELLA REGIONE LAZIO 2012-2015, 16.

Kameli, S. M., Khanehzad, M., Bagheri, S. A., & Mugahi, N. S. (2015). Investigation Excitatory and Inhibitory Effects of L-Arginine and L-NAME on Ovarian Follicles Development Process in a Pregnant Rat. Journal of Current Research in Science, 3(4), 53.

Amarendra, K. E. Overview of Pharmacovigilance.

Yarnold, P. R. Causality of Adverse Drug Reactions: The Upper-Bound of Arbitrated Expert Agreement for Ratings Obtained by WHO and Naranjo Algorithms.

Magwood-Golston, J. S., Kessler, S., & Bennett, C. L. (2016). Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry. Leukemia research, 44, 61-64.

Tuccori, M., Montagnani, S., Capogrosso-Sansone, A., Mantarro, S., Antonioli, L., Fornai, M., & Blandizzi, C. (2015). Adverse reactions to oncologic drugs: spontaneous reporting and signal detection. Expert review of clinical pharmacology, 8(1), 61-75.

Smith KA, French G, Mechor B, & Rudmik L (2015) Safety of long‐term high‐volume sinonasal budesonide irrigations for chronic rhinosinusitis. In International forum of allergy & rhinology

Rudmik L and Soler ZM (2015) Medical therapies for adult chronic sinusitis: a systematic review. Jama 314: 926-939.

Radyushkin K, Dibaj P, Martins de Souza D, Boretius S, Brzózka MM, et al. (2014) Arbeiten aus der Klinik 2014–IF 2014. MMW Fortschr Med 156: 49-51.

Soyka M (2015) Buprenorphine–naloxone buccal soluble film for the treatment of opioid dependence: current update. Expert opinion on drug delivery 12: 339-347.

Monico LB, Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, et al. (2015) Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention. Journal of substance abuse treatment 57: 57-62.

Soyka M (2015) New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone. Substance abuse and rehabilitation 6: 1.